Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating)’s stock price traded up 9.1% on Wednesday . The company traded as high as $4.12 and last traded at $4.08. 17,311 shares changed hands during trading, a decline of 97% from the average session volume of 540,391 shares. The stock had previously closed at $3.74. A number of […]
Related Keywords
Canada , Matthew Gline , Rakhi Kumar , Roivant Sciences Ltd , Goldman Sachs Group Inc , Susquehanna International Group , Nasdaq , Hsbc Holdings , Roivant Sciences , Cantor Fitzgerald , Goldman Sachs Group , Roivant Sciences Company Profile , Citigroup Inc , Royal Bank , Get Rating , Sachs Group , Sciences Company Profile , Sciences Ltd , Nasdaq Roiv , Roiv , Medical , Stocks , Technicals ,
comparemela.com © 2020. All Rights Reserved.